BIN1 and Alzheimer disease: In addition, there was no significant difference in the level of neuron-specific enolase (NSE) between the sporadic AD and control samples (mean ± SEM; 0.51 ± 0.05 pg/mL for each group, p = 0.992), indicating that the reduction in BIN1 in the sporadic AD samples was not caused by neuronal loss.